Datu, Baby Boy D.
HRN: 28-88-53 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
AMPICILLIN 250MG (VIAL)
04/19/2026
04/26/2026
IV
170MG
Q12
SEPSIS
Checking Initial Appropriateness
04/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/19/2026
04/26/2026
IV
44mg
Q24
Sepsis
Checking Initial Appropriateness
04/23/2026
CEFTAZIDIME 1GM (VIAL)
04/23/2026
04/30/2026
IV
102mg
Q12H
Neonatal Pneumonia VS Neontal Sepsis
Checking Initial Appropriateness